riboflavin ophthalmic solution
Phase 3Completed 0 views this week 0 watching💤 Quiet
Interest: 37/100
37
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 24
Phase 35
ApprovedIndication / Disease
Progressive Keratoconus
Conditions
Progressive Keratoconus
Trial Timeline
Dec 1, 2007 → Apr 1, 2011
NCT ID
NCT00647699About riboflavin ophthalmic solution
riboflavin ophthalmic solution is a phase 3 stage product being developed by Glaukos for Progressive Keratoconus. The current trial status is completed. This product is registered under clinical trial identifier NCT00647699. Target conditions include Progressive Keratoconus.
What happened to similar drugs?
2 of 20 similar drugs in Progressive Keratoconus were approved
Approved (2) Terminated (4) Active (14)
Hype Score Breakdown
Clinical
17
Activity
8
Company
12
Novelty
0
Community
0
Clinical Trials (2)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00674661 | Phase 3 | Completed |
| NCT00647699 | Phase 3 | Completed |
Competing Products
20 competing products in Progressive Keratoconus